Bausch Health Companies Inc. (BHC): Free Cash Flow
$1.00B
Year ended 2025-12-31
$1.43B
Trailing 12 months to 2026-06-30
+4.4%
5-year compound annual growth
-6.8%
10-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.00B | -20.4% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $1.26B | +54.2% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $817.00M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$946.00M | n/m | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $1.16B | +43.0% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $809.00M | -34.3% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $1.23B | -8.4% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $1.34B | -36.6% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $2.12B | +14.4% | 2020-02-19, From 2017-01-01 |
| 2016-12-31 | $1.85B | -8.4% | 2019-02-20, From 2016-01-01 |
| 2015-12-31 | $2.02B | +0.1% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $2.02B | +118.0% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $926.70M | +68.8% | 2016-04-29, From 2013-01-01 |
| 2012-12-31 | $549.00M | n/a | 2015-02-25, From 2012-01-01 |
| No annual figure between 2010-12-31 and 2012-12-31. | |||
| 2010-12-31 | $246.37M | -30.3% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $353.47M | +93.9% | 2012-02-29, From 2009-01-01 |
| 2008-12-31 | $182.33M | n/a | 2011-02-28, From 2008-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.00B | -20.4% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $2.28B | -0.7% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $3.19B | n/m |
| Viatris Inc (VTRS) | 2025-12-31 | $1.94B | -2.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $4.08B | +11.3% |
| Organon & Co. (OGN) | 2025-12-31 | $538.00M | -29.6% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.15B | +53.3% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $941.74M | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $284.00M | -27.9% |
Compare BHC, ZTS, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗